This article is more than 5 years old. Information may no longer be current.
Benvenue Medical begins full Kiva VCF system launch
Click Here to Manage Email Alerts
Benvenue Medical Inc. announced the full commercial launch of the Kiva VCF Treatment System is underway. The novel implant-based system is used for the reduction and treatment of spine fractures and vertebral augmentation, and as an alternative to balloon kyphoplasty, according to a company press release.
The Kiva System features a proprietary, cylindrical implant made from a medical polymer designed to provide predictable structural support for the vertebral body and a reservoir to contain and direct the bone cement flow. This new approach allows the physician to deliver a more consistent result.
As part of the launch, product training program is fully underway. The company continues to expand its sales distribution, network of physicians using Kiva, and hospital contracting agreements to respond to initial demand, as noted in the release.
“We are excited to provide a new alternative to the large and growing population of VCF [vertebral compression fracture] patients in the U.S. market,” Robert K. Weigle, CEO of Benvenue Medical, stated. “We believe the enthusiastic response we are enjoying is a result of, among other things, the fact that government and private payers are pushing to ensure treatment effectiveness in their reimbursement decisions.”